• News
  • Upcoming Events
  • YAFO Global Life Science Weekly

Follow us on Wechat

Yafo CEO Speaks at 19th Annual Biotech in Europe Forum

Sept 25, 2019

Sean Jiang, the CEO of Yafo Capital, participated 19th Annual Biotech in Europe Forum from 25th - 26th September 2019 at the Congress Center Basel, Switzerland. The forum provides access to an exciting cross-section of venture-funded and small-cap companies with leading investors and pharmas. Over 700 delegates and over 100 presenting companies, and 30+ pitches by seed companies have been involved.

YAFO Received “2019 Best Pharma BD Innovation Award”

September 11, 2019

Yafo capital received the “2019 Best Pharma BD Innovation Award” at the 14th China Pharmaceutical and Medtech Business Development Forum, hosted by Luye Pharmaceutical and Weijian Pharmaceutical. The Forum is organized by China Healthcare Business Development (CHBD) and Yafo Capital acts as the Forum’s designated transaction partner. Yafo Capital presented 4 overseas pharma transaction opportunities at the conference.

YAFO Host the 4th China Pharma BD Salon with Ferring

August 30, 2019

YAFO Capital office welcomed more than 20 pharmaceutical leaders to join the salon, including executives and BD Directors from Ferring Pharmaceuticals, Sinopharma, Tasly Group, CR Pharmaceutical, Wuxi Apptec, Tenry Pharmaceutical, etc.


June 05, 2019

IRVINE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced it has signed an exclusive sales and distribution agreement with MaxHealth for the sale of its EZ Detect product in China. The agreement requires MaxHealth to meet annual minimum purchase requirements, which in aggregate, equal $17 million. As previously announced, the CFDA has already cleared Biomerica’s EZ Detect™ colorectal screening test for distribution in China.

Yangtze River Pharmaceutical Group (YRPG) Visits YAFO Office to Discuss Cross-boarder Opportunities

June 3rd, 2019

On June 3rd, 2019, Mr. Cai Wei, the head of R&D Center of Yangtze River Pharmaceutical Group(YRPG), visited YAFO Capital Shanghai office with its team. YRPG has ranked No. 1 for many years among all Chinese pharmaceutical companies (Data reported by China Ministry of Industry and Information Technology).

Sean Jiang speaks at Meet Up Session at JHVS on October 12th, 2018 in Yokohama

October 12th, 2018

Comparing to the US and China, number of successful start-ups and bioventures in the healthcare sector are fewer in Japan nevertheless there are many cutting edge disruptive science from Japanese academia. What are the reasons behind?

Yafo Capital Acts as Exclusive Advisor for Synergy Pharma (SGYP) in its $68 Million Licensing Transaction

August 7, 2018

August 8, 2018 - Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) announced yesterday that the company had entered into a license agreement with Luoxin Pharmaceutical Group Co., Ltd., Shandong (Luoxin). Yafo Capital acted as the exclusive financial advisor on this transaction.

Yafo Announces a JV with COFCO to Expand into Nutrition & Food


In Feb. 2018, Yafo Capital announced a joint venture with the Nutrition & Health Research Institute (NHRI) of COFCO (China National Cereals, Oils and Foodstuffs Corporation), the world’s third largest agriculture company, to expand into nutrition and health market and agro sector. The JV will be the first IP/tech-transfer company under Central State-Owned Enterprises (CSOEs).

Yafo Capital Reaches a Strategic Partnership with Xixian Capital in Fund Management

November 30, 2017

On November 30, 2017,Yafo Capital reached a strategic partnership with Xixian Financial Holdings, a wholly owned subsidiary of Xixian New Area, China's seventh State-level development district , to invest and bring global technologies to China. Yafo Capital and Xixian Capital agreed to set up an investment fund of 5 billion RMB, with a first phase of 1 billion RMB, that will focus on healthcare, green-tech, food and agro tech, TMT, advanced manufacturing and other sectors. The fund will invest in foreign enterprises in the above sectors, aiming to bring global products and/or technologies to China in order to penetrate the Chinese market.

Benjamin Peng Shares Sino-Israel Investment Opportunities in The 5th One Belt, One Road Initiative Conference in Israel.

September 26th, 2017

Benjamin Peng, from Yafo Capital, shared his insights about China-Israel investment and business opportunities at the The 5th One Belt, One Road Initiative conference panel discussion on September 26th, 2017.

The Bnai Brith Moshe Dayan Golden Manorah Award to Benjamin Peng


It is an NGO represented at the United Nations Organization, the European Council, UNESCO and the MERCOSUR. The numerous lodges of the B’nai B’rith (Sons of the Brith) have been created by some Free Masons. They have all over the USA, South America, Europe, Australia and Israel- wherever Jewish communities exist.

The Hillel of Silicon Valley Honors Qi Li


In 2016, the Hillel of Silicon Valley honored Yafo’s own Qi Li for her Israel advocacy work in both the US and China. She is the first Chinese and alumni student to be honored by the L’Dor V’Dor (“From Generation to Generation”) program in Hillel of Silicon Valley.

Love without Boundaries – Jewish Refugees in Shanghai


A Yafo Capital sponsored art exhibition called “Love without Boundaries – Jewish Refugees in Shanghai” opened at the International Convention Center in Jerusalem on May 10th. The exhibition enshrined the history of Jews seeking shelter in Shanghai during WWII.

YAFO Pre-JMP Ski Lake Tahoe and YAFO JPM Mixing Dinner 2020

Jan 10th, 2020 | Lake Tahoe; Jan 15th, 2020 | San Francisco

Following the YAFO JPM Mixing Dinner 2019, YAFO Capital together with Renexes and CHBD will provide an exciting Pre-JPM networking event that combining ski and fireside chat this year. The Mixing Dinner in San Francisco will include 50 to 100 people this year from China, Japan and US. The Pre-JPM Ski Tahoe and the Bio Fireside Chat event will be held at a ski resort in Lake Tahoe.

China Healthcare Investment Conference (CHIC)

March 26 -28, 2019 | Shanghai, China

In 2010, recognizing that the healthcare reform and industry growth was spurring a new wave of emerging Chinese healthcare companies, a group of investors led the efforts to organize China Healthcare Investment Conference (CHIC). This prestigious event has since grown into the most powerful platform to promote and nurture the Chinese healthcare investment ecosystem and further develop the industry.

2019 Forum on Discovery & Development of NASH Drugs

March 29-30, 2019 | Shanghai

NASH (non-alcoholic steatohepatitis) is a huge unmet clinical need, and behind it is a new drug opportunity that cannot be missed.




一周医刊|含金汤匙出生 Viela剥离出阿斯利康同时获2.5亿美金


含金汤匙出生:Viela Bio剥离出阿斯利康同时获2.5亿美金融资;站在巨人的肩膀上:由illunima创立的血液诊断独角兽公司Grail拟在港上市。

二月医刊 | 罗氏、哈药、乐普又搞大动作!



一周医刊 | 亚马逊联手巴菲特与摩根大通建立医疗公司


亚马逊联手巴菲特与摩根大通建立医疗公司 为自家员工谋福利;国内心理健康管理公司安肯医疗获国药资本数千万人民币融资;叮当快药和WeGene完成新一轮融资,互联网医疗迎来新零售风口。

一周医刊 | 赛诺菲开启买买买模式